Financial Times US Healthcare and Life Sciences Conference

Venue: Metropolitan Club

Location: New York, New York, United States

Event Date/Time: Jun 06, 2013 / 8:00 am - (EST) End Date/Time: Jun 06, 2013 / 5:00 pm - (EST)
Registration Date: Jun 06, 2013
Early Registration Date: May 05, 2013 Time: 23:59:00 - (EST)
Report as Spam


The FT US Healthcare and Life Sciences Conference will bring together a distinguished line-up of industry experts, government decision-makers and leading market commentators to review the shifting sands of the US healthcare industry, and explore direct and indirect implications of reform for key stakeholders-payers, life science companies, healthcare providers, investors and patients.


The conference will build on some of last year's themes and will also focus on the practicalities of dealing with the provisions and impacts of US healthcare reform-taking its core theme as "Transformation Beyond Reform". There is real appetite to know what the establishment of new institutions such as Accountable Care Organisations (ACOs) will mean for the future prospects for life science companies - are they a threat or an opportunity - and how changes in the payer/healthcare industry landscape, and their growing emphasis on the value they provide rather than products, might impact the industry's future profitability.  The conference will also focus on other topical themes such as:


  • New models for financing R&D 
  • Opportunities in emerging markets beyond the BRIC countries as the next range of countries start to attract the attention of life science companies
  • Challenges and opportunities represented by the increasing convergence between pharmacy diagnostic and devices companies and products


One East 60th Street (at Fifth Avenue)
New York
New York
United States

Conference Speakers


Ian Read, President and CEO, Pfizer David Meeker, MD, President, CEO, Genzyme Jeff George, Global Head, Sandoz and Executive Committee Member, Novartis Tom Pike, CEO, Quintiles Jan Groen, PhD, CEO, MDxHealth Jan Lundberg, PhD, EVP, Science and Technology and President, Lilly Research Laboratories Jonathan Sheffield, CEO, NIHR Clinical Research Network Dirceu Bras Aparecido Barano, Chairman, Anvisa  Reynold (Pete) Mooney, Global Leader, Life Sciences and Health Care, Deloitte Touche Tohmatsu Terry Hisey, Vice Chairman, US Life Sciences Leader, Deloitte Fred Hassan, Managing Director, Healthcare, Warburg Pincus Paul Hudson, EVP, North America, AstraZeneca Kevin Lobo, President and Chief Executive Officer, Stryker Amy Schulman, EVP and General Counsel; Business Unit Lead, Consumer Healthcare, Pfizer Arthur Higgins, Senior Consultant, Blackstone Healthcare Partners Colin Hill, CEO and Co-Founder, GNS Healthcare Mara Aspinall, President, Ventana Medical Systems; Head, Roche Tissue Diagnostics Michael Warmuth, EVP, Established Pharmaceuticals, Abbott

Additional Information


This event is for CEOs, CFOs, CIOs, Chief Medical Officers, Chief Strategy Officers, Heads of R&D, Emerging Markets, Consumer Health, Government Relations, Pricing, Regulation, etc. and other senior-level executives in the following sectors:

  • Pharmaceuticals, Biotechnology, Generic and Specialty Pharmaceutical companies
  • Medical Devices and Diagnostics
  • Investment (Fund Managers, Venture Capitalists, Private Equity firms, Investment Bankers, IP Groups)
  • Legal Counsel
  • Healthcare IT (Patient records, data, mobile healthcare applications, social media)
  • Regulation